Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: Joint Symptoms More Common In Breast Cancer Patients
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
systemic sclerosis;Anti-PDGFR-alpha antibodies Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis
Annals of Rheumatic Diseases, 07/14/08
Print     Email This Article     Save in My Library   Free Abstract
Balada E et al. - Although anti-PDGFR-α antibodies seem to be disease-specific when determined by bioactivity assays, these antibodies are also detected in normal subjects when immunological methods are used. Thus, anti-PDGFR-α antibodies may arise from natural autoantibodies.

Methods
  • Study to evaluate the presence of anti-PDGFR-α abs by immunological methods in pts with SSc
  • 58 women diagnosed with SSc and 36 healthy women controls
  • IgG anti-PDGFR-α were measured by ELISA and immunoblot
  • Associations with clinical and immunological findings were also studied

Results
  • Non-significant differences were detected between pts with SSc and controls
  • No correlation between the presence of anti-PDGFR-α abs and clinical and serological features
  • Serum samples from pts with SSc and healthy people who had high titres of anti-PDGFR-α abs by ELISA recognised the same band corresponding to PDGFR-α by immunoblot

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- CONNECTIVE TISSUE DZ TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.